www.alldocs.info « cancers »
by www.alldocs.info
the most recent document references on :: cancers
Google
 
 Web   cancers.alldocs.info 
 
    Languages: malattie oncologiche  cancers  cancer  cancer  Krebse          Found 1931 documents         Page 6 of 65   Pages:  <<  <  1  2  3  4  5  6  7  8  9  10  11  >  >> 
 
 
 
   cancers cancers
     bladder cancer bladder cancer
     brain cancer brain cancer
     breast cancer breast cancer
     colon cancer colon cancer
     gastrointestinal cancer gastrointestinal cancer
     kidney cancer kidney cancer
     laryngeal cancer laryngeal cancer
     leukaemia leukaemia
     liver cancer liver cancer
     lung cancer lung cancer
     lymphoma lymphoma
     myeloma myeloma
     neuroblastoma neuroblastoma
     ovarian cancer ovarian cancer
     pancreatic cancer pancreatic cancer
     prostate cancer prostate cancer
     stomach cancer stomach cancer
     testicular cancer testicular cancer
     thyroid cancer thyroid cancer
     uterine cancer uterine cancer
     prevention prevention
     diagnosis diagnosis
     therapies therapies
  cancers.alldocs.infohomepage
www.alldocs.infowww.alldocs.info


 

  Legenda: last week last month

  [151] COLORECTAL CANCER: MYTHS AND REALITIES
      PDF [60,5 KB]  From [www.preventcancer.org]  Last viewed: 07.09.2006
COLORECTAL CANCER : MYTHS AND REALITIES MYTH: There is nothing I can do about getting colorectal cancer . REALITY: Colorectal cancer can be prevented. Screening tests can detect polyps (grape-like growths on the lining of the colon or rectum) that can turn into cancer . Removing these polyps can prevent colorectal cancer from ever occurring . Starting at age 50, men and women who are at aver- age risk should be screened regularly for colorectal cancer . New research shows that African Americans should begin screening at age 45. Men and women who are at high risk of the disease because of personal and family medical history may need to be tested earlier and should talk with their health care professional about when. MYTH: Colorectal cancer is usually fatal. REALITY: Colorectal cancer is usually curable when detected early. More than 90 percent of patients with localized ...

  [152] Facts About Cervical Cancer
      PDF [53,0 KB]  From [michigan.gov]  Last viewed: 07.09.2006
Facts About Cervical Cancer December 2005 What You Should Know No one should die from cervical cancer . If detected early, all deaths from cervical cancer can be prevented through appropriate treatment. Cervical cancer can be detected early by regular Pap smear tests. Most cervical cancers develop over a relatively long period of time. During this time, abnormal tissue can be detected easily by a Pap smear and then removed by a health care provider. Experts believe that virtually all cervical cancer deaths could be prevented by a combination of safe sex practices, routine Pap smears, and appropriate follow-up of abnormal screening results. Cervical cancer is one of the few cancers that can be prevented by using the same precautions as with other sexually transmitted diseases. The Michigan Cancer Consortium, ...

  [153] ARE YOU AT RISK FOR COLORECTAL CANCER?
      PDF [56,0 KB]  From [www.preventcancer.org]  Last viewed: 07.09.2006
ARE YOU AT RISK FOR COLORECTAL CANCER ? S tarting at age 50, men and women who are at average risk of colorectal cancer should be screened regularly. Nearly 90 percent of all cases of colorectal cancer are diagnosed in people older than 50. Some men and women are at higher risk of the disease and may need to be tested earlier. Those at higher risk include: • People with a personal or family history of benign colorectal polyps. • People with a personal or family history of colorectal cancer . • People with a personal or family history of inflammatory bowel disease — ulcerative colitis or Crohn’s. • Men and women who use tobacco, drink too much alcohol, are overweight or do not lead an active life. • African Americans appear to be at higher risk for the disease and are often diagnosed at a younger age — they may need to begin screening at age 45. March ...

  [154] Ciphergen Launches Breast Cancer Diagnostic Development Program .,
      PDF [120,9 KB]  From [www.ciphergen.com]  Last viewed: 07.09.2006
Page 1 of 2 For Immediate Release: Ciphergen Biosystems, Inc. Sue Carruthers Investor Relations (510) 505 2297 Ciphergen Launches Breast Cancer Diagnostic Development Program Two studies published this month confirm overlapping biomarkers for early detection of breast cancer Fremont, CA, December 8, 2005 – Ciphergen Biosystems, Inc. (Nasdaq: CIPHE) announced today it is launching a formal breast cancer diagnostic development program based on a series of discoveries made using Ciphergen’s Surface Enhanced Laser Desorption/Ionization (SELDI) technology and PatternTrack™ biomarker discovery process. The original study by Li (Clinical Chemistry 48(8) 1296-1304) published in 2002 detailed the discovery of three serum biomarkers that can improve detection of breast cancer . Two of the three markers have been identified and validated by two studies published this month. ...

  [155] Cancer of the Thyroid
      PDF [50,9 KB]  From [www.thyroid.org]  Last viewed: 07.09.2006
ADDITIONAL PATIENT RESOURCES WWW.THYROID.ORG For further details on this and other thyroid-related topics, please visit the patient resources section on the American Thyroid Association website at www.thyroid.org 1 SYMPTOMS What is thyroid cancer and its symptoms? Thyroid cancer is the most common endocrine-related cancer .The outlook for patients with thyroid cancer is excellent in that safe and effective therapy is available in most cases.A lump (nodule) in the thyroid is the key sign of its presence.Most thyroid cancers do not cause any symptoms,and only rarely do they cause pain,difficulty in swallowing,or hoarseness. CAUSES What causes thyroid cancer ? Thyroid cancer is more common in people who have a history of exposure of the thyroid gland to radiation,have a family history of thyroid cancer ,and are older than 40 years of age. DIAGNOSIS ...

  [156] Non-Hormonal Systemic Therapy in Men with Metastatic Hormone ...
      PDF [128,7 KB]  From [www.cancercare.on.ca]  Last viewed: 07.09.2006
PRACTICE GUIDELINE – page 1 Evidence-based Series #3-15: Section 1 Non-Hormonal Systemic Therapy in Men with Metastatic Hormone- Refractory Prostate Cancer : A Clinical Practice Guideline E. Winquist, T. Waldron, S. Berry, D.S. Ernst, S. Hotte, H. Lukka, and members of the Genitourinary Cancer Disease Site Group A Quality Initiative of the Program in Evidence-based Care (PEBC), Cancer Care Ontario (CCO) Developed by the Genitourinary Cancer Disease Site Group Report Date: November 1, 2005 Question Which non-hormonal systemic therapies are most beneficial and should be recommended for the treatment of hormone-refractory prostate cancer ? First-line cytotoxic and non-cytotoxic systemic therapies are the agents of interest. Overall survival, disease control (as assessed by measures such as progression-free survival, time-to-progression, time-to-treatment ...

  [157] US Cancer Management Corporation Case Study
      PDF [208,2 KB]  From [www-03.ibm.com]  Last viewed: 07.09.2006
National Overview Breast Cancer Services www.clinicalstandards.org Clinical Standards Board for Scotland Page 2 © CSBS 2002 ISBN 1-903766-74-5 First published March 2002 Further details on the process by which the Board will achieve its objectives can be found in the comprehensive Clinical Standards Board for Scotland (CSBS) ‘Quality Assurance & Accreditation Manual’ (August 2000). Copies of the Clinical Standards for Breast Cancer are also available from CSBS. The CSBS consents to the photocopying, electronic reproduction by ‘upload- ing’ or ‘downloading’ from the website, retransmission, or other copying of the findings of this report for the purpose of implementation in NHSScotland. Clinical Standards Board for Scotland Elliott House 8-10 Hillside Crescent Edinburgh EH7 5EA Copies of this report and of the reports ...

  [158] SIGN Guideline No. 75 Epithelial ovarian cancer
      PDF [785,3 KB]  From [www.sign.ac.uk]  Last viewed: 07.09.2006
For more information about breast health or breast cancer , call the Susan G. Komen Breast Cancer Foundation’s Toll-Free Helpline at 1.800 I’M AWARE ® (1.800.462.9273) or visit the Web site at www.komen.org. genetics & breast cancer Who has mutations in BRCA1 and BRCA2? The likelihood that you have mutations in the BRCA1 or BRCA2 genes is greater if one or more of the following statements is true for you: you are younger (below age 50) your mother, sister or daughter has had breast cancer before age 50 or ovarian cancer at any age a woman in your family has had both breast cancer and ovarian cancer a woman in your family has had breast cancer in both breasts your family is of Ashkenazi Jewish descent there is male breast cancer in your family Remember, most women who get breast cancer do not have an inherited gene mutation in ...

  [159] Management of patients with lung cancer SIGN Guideline No. 80
      PDF [702,5 KB]  From [www.sign.ac.uk]  Last viewed: 07.09.2006
For more information about breast health or breast cancer , call the Susan G. Komen Breast Cancer Foundation’s Toll-Free Helpline at 1.800 I’M AWARE ® (1.800.462.9273) or visit the Web site at www.komen.org. genetics & breast cancer Who has mutations in BRCA1 and BRCA2? The likelihood that you have mutations in the BRCA1 or BRCA2 genes is greater if one or more of the following statements is true for you: you are younger (below age 50) your mother, sister or daughter has had breast cancer before age 50 or ovarian cancer at any age a woman in your family has had both breast cancer and ovarian cancer a woman in your family has had breast cancer in both breasts your family is of Ashkenazi Jewish descent there is male breast cancer in your family Remember, most women who get breast cancer do not have an inherited gene mutation in ...

  [160] SIGN publication no. 44 - Control of pain in patients with cancer
      PDF [630,1 KB]  From [www.sign.ac.uk]  Last viewed: 07.09.2006
Cancer of the Penis Mariela R.Pow-Sang, MD,Victor Benavente, MD, Julio E.Pow-Sang, MD, Carlos Morante, MD, Luis Meza, MD, Mark Baker, MD, and Julio M.Pow-Sang, MD Background: Cancer of the penis is an uncommon malignancy in developed countries, but the incidence is as high as 17% of all male cancers in some undeveloped countries. The surgical management of this disease has improved due to better knowledge of risk for metastasis and newer imaging technologies to assess the regional lymph nodes. Methods : We review the literature on incidence, etiology, pathology, clinical presentation, staging, and management of penile cancer . We present our institutional experience with 160 patients who underwent extended ileoinguinal lymph node dissection, as well as with 7 patients who underwent a modified lymph node dissection. Results: Better understanding of pathologic features allow for ...

  [161] Secondary breast cancer
      PDF [220,8 KB]  From [www.breastcancercare.org.uk]  Last viewed: 07.09.2006
Secondary breast cancer Page 2 Breast Cancer Care is the UK’s leading provider of information, practical assistance and emotional support for anyone affected by breast cancer . Every year we reach over 750,000 people with breast cancer or breast health concerns. All our services are free. For more information call the Breast Cancer Care helpline free on 0808 800 6000 (textphone 0808 800 6001) or visit www.breastcancercare.org.uk. Page 3 Contents Introduction 2 Secondary breast cancer 3 Finding out 5 Psychological effects 7 Anxiety and stress 8 Depression 10 Physical effects 11 Pain 11 Nausea and vomiting 13 Constipation 13 Poor appetite 14 Weight gain 15 Fatigue 15 Treatment ...

  [162] Breast Cancer
      PDF [1801,1 KB]  From [www.titans.uwosh.edu]  Last viewed: 07.09.2006
I would like to purchase: _ (quantity) hat(s) at $20 per hat for a total of $_. _ (quantity) wristbands at $1 per wristband for a total of $_. $ (dollar amount) season-long freethrow pledge (400 free throws at a $.25 pledge will amount to a $100 donation) Donation only $__ Name:__ Company name:_ Home address:_ Business address:__ City, state, zip code: Phone: ( )_ E-mail: __ $ total of purchase Method of payment (check one): __Check/cash __Bill me __Credit card l MasterCard l Visa Cardholder’s name: Card No.: Exp. date (mm/yy): _ Like so many community members, the athletes and coaching staff of the University of Wisconsin- Oshkosh women’s basketball have been affected by breast cancer . They know survivors or someone currently undergoing treatment or even a loved one who died of breast cancer . That is why the UW ...

  [163] Tips for Teens with Cancer
      PDF [61,5 KB]  From [www2.texaschildrenshospital.org]  Last viewed: 07.09.2006
Texas Children’s Cancer Center and Hematology Service Tips for Teens with Cancer Exercise Of course you can be fit. You want to be able to strengthen your heart and lungs, stretch your muscles, move your joints smoothly and fully, and build endurance. What you can do: • walk • hike • play Frisbee • play putt-putt golf • swim (at the beach, too) If your platelet count is low, avoid activities such as contact sports, roller blading, mountain biking, horse back riding, and weight lifting. Talk with your doctor or nurse about these sports. And wear sunscreen anytime you’re outside. (See Sun on the other side for the why’s and wherefore’s.) Weight Whether it’s losing weight or gaining weight, it never seems easy. Here are some ideas: To gain weight • Drink milkshakes. • Dip veggies in peanut butter. • Add cheese to any food. ...

  [164] Cancer Care Ontario Practice Guidelines Initiative
      PDF [535,6 KB]  From [www.cancercare.on.ca]  Last viewed: 07.09.2006
Evidence-based Series #2-15: Section 1 Oral Capecitabine (Xeloda ) in the First-line Treatment of Metastatic A Clinical Practice Guideline W Koc intestinal Cancer Disease ence-based Care. the Program in Evidence-based Care (PEBC), Cancer Care Ontario (CCO) Developed by the Gastrointestinal Cancer Disease Site Group 11, 2005 ent of patients ther thymidylate st, and time-to- ion er, who have not notherapy with nts who are at a erapy, adjuvant diagnosed with Recommendations • In appropriate patients, standard combination chemotherapy consists of infusional 5- fluouracil plus leucovorin calcium with either irinotecan or oxaliplatin (refer to the Program in Evidence-based Care’s Practice Guideline #2-16b: Use of Irinotecan (Camptosar®, CPT-11) Combined with 5-fluorouracil and Leucovorin (5FU/LV) as First-line ...

  [165] Laparoscopic Surgery for Cancer of the Colon
      PDF [153,0 KB]  From [www.cancercare.on.ca]  Last viewed: 07.09.2006
EVIDENCE-BASED SERIES #2-20-2 Evidence-based Series #2-20-2 Laparoscopic Surgery for Cancer of the Colon A. Smith, R.B. Rumble, B. Langer, H. Stern, F. Schwartz, M. Brouwers, and members of Cancer Care Ontario’s Laparoscopic Colon Cancer Surgery Expert Panel and Program in Evidence-based Care Report Date: September 2005 Evidence-based Series #2-20-2 is comprised of 3 sections: Section 1: A Clinical Practice Guideline Section 2: A Systematic Review Section 3: Guideline Development and External Review: Methods and Results A Quality Initiative of Cancer Care Ontario’s Surgical Oncology Program and the Program in Evidence-based Care For further information about this series, please contact: Dr. Andy Smith Toronto-Sunnybrook Hospital 2075 Bayview Avenue Toronto, ON. M4N 3M5 Email: andy.smith@sw.ca TEL: 416-480-4027 ...

  [166] Laparoscopic Surgery for Cancer of the Colon
      PDF [223,7 KB]  From [www.cancercare.on.ca]  Last viewed: 07.09.2006
EVIDENCE-BASED SERIES #2-20-2 Evidence-based Series #2-20-2 Laparoscopic Surgery for Cancer of the Colon A. Smith, R.B. Rumble, B. Langer, H. Stern, F. Schwartz, M. Brouwers, and members of Cancer Care Ontario’s Laparoscopic Colon Cancer Surgery Expert Panel and Program in Evidence-based Care Report Date: September 2005 Evidence-based Series #2-20-2 is comprised of 3 sections: Section 1: A Clinical Practice Guideline Section 2: A Systematic Review Section 3: Guideline Development and External Review: Methods and Results A Quality Initiative of Cancer Care Ontario’s Surgical Oncology Program and the Program in Evidence-based Care For further information about this series, please contact: Dr. Andy Smith Toronto-Sunnybrook Hospital 2075 Bayview Avenue Toronto, ON. M4N 3M5 Email: andy.smith@sw.ca TEL: 416-480-4027 ...

  [167] Cancer prevention and control
      PDF [29,0 KB]  From [www.iacr.com.fr]  Last viewed: 07.09.2006
FIFTY-EIGHTH WORLD HEALTH ASSEMBLY WHA58.22 Agenda item 13.12 25 May 2005 Cancer prevention and control The Fifty-eighth World Health Assembly, Having examined the report on the prevention and control of cancer ; Recalling resolutions WHA51.18 and WHA53.17 on the prevention and control of noncommunicable diseases, WHA57.17 on the Global Strategy on Diet, Physical Activity and Health, WHA56.1 on tobacco control, and WHA57.12 on the reproductive health strategy, including control of cervical cancer , and WHA57.16 on health promotion and healthy lifestyles; Recognizing the suffering of cancer patients and their families and the extent to which cancer threatens development when it affects economically active members of society; Alarmed by the rising trends of cancer risk-factors, the number of new cancer cases, and cancer morbidity and mortality worldwide, in particular ...

  [168] 5527 RCN Gynae Cancer Text
      PDF [317,4 KB]  From [www.rcn.org.uk]  Last viewed: 07.09.2006
R O Y A L C O L L E G E O F N U R S I N G Gynaecological cancer Guidance for nursing staff Page 2 Published by the Royal College of Nursing,20 Cavendish Square,London,W1G 0RN © 2005 Royal College of Nursing.All rights reserved.No part of this publication may be reproduced,stored in a retrieval system,or transmitted in any form or by any means electronic,mechanical,photocopying,recording or otherwise,without prior permission of the Publishers or a licence permitting restricted copying issued by the Copyright Licensing Agency,90 Tottenham Court Road,London W1T 4LP.This publication may not be lent,resold, hired out or otherwise disposed of by ways of trade in any form of binding or cover other than that in which it is published,without the prior consent of the Publishers. This guidance publication provides information on: ? cancer of the cervix ? ...

  [169] Frequently Asked Questions About Hereditary Breast Cancer
      PDF [58,7 KB]  From [www.brca.com]  Last viewed: 07.09.2006
Frequently Asked Questions About Hereditary Breast Cancer All cancer involves changes in genes called mutations. However, in most people, these changes occur after birth, usually later in life and only in a limited number of the body’s cells. Hereditary cancer refers to cancer that is caused by a mutation that is present at birth and in all cells of the body. This gene change makes individuals more likely to develop cancer in their lifetime but doesn't mean they will definitely develop the disease. Certain cancers , including those of the breast, ovary, and colon, are more likely than others to be hereditary. This fact sheet will answer questions on hereditary breast cancer . It might not answer all your questions because the issue of hereditary breast cancer is very complex. We have provided a listing of helpful resources at the end of this sheet where you can get more information. ...

  [170] Cancer of the Colon and the Rectum
      PDF [55,1 KB]  From [www.4woman.gov]  Last viewed: 07.09.2006
F R E Q U E N T LY A S K E D Q U E S T I O N S WomensHealth.gov 1-800-994-9662 TDD: 1-888-220-5446 Q: Why should I be concerned about cancer of the colon and the rectum? Cancer of the A: Colorectal cancer affects an equal Colon and the number of women and men each year, and is most often found in people over the age of 50. Excluding skin cancer , it Rectum is the third most diagnosed cancer for women, following breast and lung cancers . And it is the second leading cause of cancer death in the United Q: What is cancer of the colon and States. Colorectal cancer is often called the rectum? a “silent” disease since symptoms don’t A: Cancer is a disease in which certain always develop ...

  [171] Ovarian Cancer
      PDF [49,5 KB]  From [www.4woman.gov]  Last viewed: 07.09.2006
F R E Q U E N T LY A S K E D Q U E S T I O N S WomensHealth.gov 1-800-994-9662 TDD: 1-888-220-5446 cer. Most cases occur in women over Ovarian Cancer the age of 50, but this disease can also affect younger women. Ovarian cancer causes more deaths than any other can- Q: What is ovarian cancer ? cer of the female reproductive system. A: Cancer is a disease in which certain The sooner ovarian cancer is found and treated, the better a woman’s chance for body cells don’t function right, divide recovery. But ovarian cancer is hard to very fast, and produce too much tissue detect early. Many times, women with that forms a tumor . Ovarian cancer is ovarian cancer have no symptoms or cancer in the ovaries, the female repro- just mild symptoms until ...

  [172] Lung Cancer
      PDF [51,4 KB]  From [www.4woman.gov]  Last viewed: 07.09.2006
F R E Q U E N T LY A S K E D Q U E S T I O N S WomensHealth.gov 1-800-994-9662 TDD: 1-888-220-5446 Q: Why should I be concerned about lung cancer ? Lung Cancer A: Did you know that lung cancer kills more women every year than breast cancer ? Researchers continue to study Q: What is lung cancer ? the causes of lung cancer and to search A: Cancer is a disease in which certain body cells don’t function right, divide very fast, and produce too much tissue that forms a tumor . The lungs, a pair of sponge-like, cone-shaped organs, are part of the body’s respiratory system. When we breathe in, the lungs take in oxygen, which our cells need to live and carry out their normal functions. When we breathe out, the lungs get rid of ...

  [173] Table 1. Cervical Cancer Screening Guidelines
      PDF [514,3 KB]  From [www.cdc.gov]  Last viewed: 07.09.2006
Table 1. Cervical Cancer Screening Guidelines American Cancer Society 1 (ACS, Nov 2002) U. S. Preventive Services Task Force 2 (USPSTF, Jan 2003) American College of Obstetricians and Gynecologists 3 (ACOG, Aug 2003) When to start Approximately 3 years after onset of vaginal intercourse, but no later than age 21 Within 3 years of onset of sexual activity or age 21, whichever comes first Approximately 3 years after onset of sexual intercourse, but no later than age 21 Intervals Conventional Pap test If liquid-based cytology used** If HPV testing used** Annually; every 2-3 years for women =30 with 3 negative cytology tests* Every 2 years; every 2-3 years for women =30 with 3 negative cytology tests* Every 3 years if HPV negative, ...

  [174] WHO Cancer Control Strategy
      PDF [20,9 KB]  From [www.meet-ics.com]  Last viewed: 07.09.2006
WHO Cancer Control Strategy As a response to the cancer epidemic, and following the approval of the Resolution on Cancer Prevention and Control by the Executive Board (EB114/R2) for its adoption at the 58th WHA in May 2005, the Director-General has recently approved the development of various activities for cancer prevention and control. These activities include a Global Cancer Control Strategy, the publication of " Cancer Contol: Knowledge into Action - WHO Guide for Effective Programmes", and the establishment of groups to support these activities (e.g. a WHO Cancer Steering Group , a Cancer Advisory Committee to the Director-General; a Cancer Technical Group , and a WHO Cancer Network of Partners . The aim of the WHO Cancer Control Strategy is to strengthen and accelerate the translation of cancer control knowledge into public health action. The focus is placed on countries to ensure ...

  [175] GS 62 PREVENTING SKIN CANCER
      PDF [219,7 KB]  From [www.eric.sa.gov.au]  Last viewed: 07.09.2006
This information is provided to offer guidance on a particular aspect of legislation. It is not to be taken as a statement of law and must not be construed to waive or modify any legal obligation GS 62 PREVENTING SKIN CANCER ASK YOURSELF: 1. How much of your working life is spent outdoors? 2. At what time of the day do you generally work outdoors? 3. Do you have natural shade areas available? 4. How do you currently protect yourself from the sun? WHY IS SKIN CANCER A RISK? Exposure to ultraviolet radiation (UVR) from the sun is the major cause of skin cancers in Australia. Outdoor workers have a high risk of developing skin cancers , as they are continually exposed to ultraviolet radiation. UV exposure from the sun is greatest between 10 am and 2 pm (11 am and 3 pm daylight saving time) because the sun’s rays are more direct. Clouds ...

  [176] Cancer Care Ontario Practice Guidelines Initiative
      PDF [146,7 KB]  From [www.cancercare.on.ca]  Last viewed: 07.09.2006
Use of Gemcitabine in the Treatment of Advanced Pancreatic Adenocarcinoma Practice Guideline Report #2-10 Germond C, Maroun J, Moore M, Zwaal C, Wong S, and members of the Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-based Care. Report Date: June 24, 2005 ORIGINAL GUIDELINE: May 22, 1998 MOST RECENT LITERATURE SEARCH: March 9, 2005 NEW EVIDENCE ADDED TO GUIDELINE REPORT: June 24, 2005 New evidence found by update searches since completion of the original guideline is consistent with the original recommendations. SUMMARY Guideline Question Should gemcitabine be offered as treatment to patients with unresectable or advanced pancreatic adenocarcinoma? Target Population These recommendations apply to adult patients with unresectable or advanced pancreatic adenocarcinoma. Recommendations • ...

  [177] breast cancer detection
      PDF [81,2 KB]  From [alt.coxnewsweb.com]  Last viewed: 07.09.2006
For more information about breast health or breast cancer , call the Susan G. Komen Breast Cancer Foundation’s Toll-Free Helpline at 1.800 I’M AWARE ® (1.800.462.9273) or visit the Web site at www.komen.org. breast cancer detection Breast cancer screening methods Mammogram — A mammogram is an X-ray picture of the breast. It is done with a special X-ray machine designed just for this purpose. A mammogram can find many cancers before they can be felt. Find your age on the chart below to see which screening methods you should do and how often you should do them. Clinical breast exam — A breast exam by a health care provider should be part of your regular medical checkup. If it is not, ask for it. A clinical breast exam includes a visual examination and carefully feeling the entire breast and underarm area. If you are 40 or older, schedule your mammogram ...

  [178] breast cancer risk factors
      PDF [67,9 KB]  From [alt.coxnewsweb.com]  Last viewed: 07.09.2006
What affects your risk of getting breast cancer ? The causes of breast cancer are not fully known. However, health and medical researchers have identified a number of factors that increase a woman’s chances of getting breast cancer . These are called risk factors. Risk factors are not necessarily causes of breast cancer , but are associated with an increased chance of getting breast cancer . Importantly, some women have many risk factors but never get breast cancer , and some women have few or no risk factors but do get the disease. Being a woman is the number one risk factor for breast cancer . For this reason, it is important to have routine mammograms, get regular clinical breast exams and perform monthly breast self-exams (BSE) in order to detect any problems early. See your health care provider to discuss your personal risk and your breast health needs. There are some risk factors you can control, ...

  [179] breast cancer facts
      PDF [97,9 KB]  From [alt.coxnewsweb.com]  Last viewed: 07.09.2006
For more information about breast health or breast cancer , call the Susan G. Komen Breast Cancer Foundation’s Toll-Free Helpline at 1.800 I’M AWARE ® (1.800.462.9273) or visit the Web site at www.komen.org. menopause after age 55 or never having children account for only a small number of new breast cancer cases every year.That means that the major- ity of women who get breast cancer have no known risk factors except being a woman and getting older. I have a family history of breast cancer . Does that mean I’ll develop breast cancer , too? Not necessarily. Just because other family members have had breast cancer doesn’t mean that their disease was inherited. Only about 5 to 10 percent of all breast cancers occur because of inherited mutations. 2 If I am diagnosed with breast cancer , what are my chances of surviving? ...

  [180] Estimation of the Baseline Number of Cancers Among Marshallese and ...
      PDF [365,3 KB]  From [marshall.csu.edu.au]  Last viewed: 07.09.2006
Estimation of the Baseline Number of Cancers Among Marshallese and the Number of Cancers Attributable to Exposure to Fallout from Nuclear Weapons Testing Conducted in the Marshall Islands Prepared by the Division of Cancer Epidemiology and Genetics National Cancer Institute National Institutes of Health Department of Health and Human Services Prepared for Senate Committee on Energy and Natural Resources September, 2004 Page 2 1 Estimation of the Baseline Number of Cancers Among Marshallese and the Number of Cancers Attributable to Exposure to Fallout from Nuclear Weapons Testing Conducted in the Marshall Islands I. INTRODUCTION From 1946 through 1958, 66 nuclear weapons tests, in seven series, were carried out by the United States at Bikini and Enewetak Atolls in ...